A First-in-Human Single and Multiple Ascending Dose Study of MT-201

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
First-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple doses of MT-201 in healthy participants.
Epistemonikos ID: 3b232fdc9aa6494bdd405a4b54f0fb85242b12f3
First added on: Oct 22, 2025